Stronger social networks could help with management of colorectal cancer
Can't see this email? View it online
   
  December 6, 2017  
  Bowel Cancer  
  The latest bowel cancer news from News Medical  
 Stronger social networks could help with management of colorectal cancerStronger social networks could help with management of colorectal cancer
 
Researchers from Brigham and Women's Hospital led by Ying Bao, MD, ScD, an epidemiologist in BWH's Channing Division of Network Medicine and Assistant Professor at Harvard Medical School, have found that women with stronger social networks had better survival after colorectal cancer diagnosis and conclude that social network strengthening could be a tool for management of colorectal cancer.
 
 
 ACS program effective in improving colorectal cancer screening ratesACS program effective in improving colorectal cancer screening rates
 
A new study suggests that an American Cancer Society program has been effective in promoting improvements in colorectal cancer screening rates in federally qualified health centers.
 
   Primary tumor-associated bacteria also present in metastatic sites, study findsPrimary tumor-associated bacteria also present in metastatic sites, study finds
 
The same bacteria present in primary tumors of patients with colorectal cancer are also present in liver metastases, a new study finds.
 
   Molecule plays double role in maintaining gut health and promoting diseasesMolecule plays double role in maintaining gut health and promoting diseases
 
A molecule that controls intestinal cell growth plays a dual role maintaining gut health and promoting diseases such as cancer, says a study in eLife.
 
   Urban American-Indian, Alaskan Native community more likely to have lower cancer survival ratesUrban American-Indian, Alaskan Native community more likely to have lower cancer survival rates
 
Compared with the non-Hispanic white population, the urban American-Indian and Alaskan Native (AIAN) community was more likely to have lower survival rates following invasive prostate and breast cancer.
 
 Immune-boosting drug combination may hold promise for treating ovarian cancer
 
Immune-boosting drug combination may hold promise for treating ovarian cancerJohns Hopkins Kimmel Cancer Center researchers demonstrated that mice with ovarian cancer that received drugs to reactivate dormant genes along with other drugs that activate the immune system had a greater reduction of tumor burden and significantly longer survival than those that received any of the drugs alone.
 
 
 Extramammary Paget’s Disease (EMPD) Overview
 
Extramammary Paget’s Disease (EMPD) OverviewExtramammary Paget disease or EPMD is a rare disease characterized by the appearance of a chronic skin rash, resembling eczema, in the genital areas.
 
 
 Scientists investigate new role of old protein in breast cancer
 
Scientists investigate new role of old protein in breast cancerScientists led by Dr Chris Toseland of the University's School of Biosciences studied a protein called Myosin VI, a molecular motor which acts as a courier to transport other proteins within our cells.
 
 
 4 in 10 cancers preventable by adopting simple lifestyle changes
 
4 in 10 cancers preventable by adopting simple lifestyle changesIn a new research that comes via the American Cancer Society, it has been seen that over 40 percent of all cancers and nearly one in two cancer deaths can be prevented by incorporating simple lifestyle changes in daily routines.
 
 
 Tobacco companies finally own up to cigarette smoking risks
 
Tobacco companies finally own up to cigarette smoking risksIt has been a decade since federal courts have found tobacco companies to be deceiving the general public by hiding the exact level of risk associated with cigarette smoking. Now finally the tobacco companies have agreed to own up the risks and air a set of advertisements on television and newspapers to correct the statements they have been making until now.
 
 
 Researchers question exclusion of people with prior cancer history from clinical trials
 
Researchers question exclusion of people with prior cancer history from clinical trialsA quarter of newly diagnosed cancer patients 65 or older are survivors who had a prior cancer – often preventing them from participating in clinical trials, researchers from UT Southwestern's Simmons Cancer Center have found.
 
 
 Findings reveal consistent racial disparities in ovarian, colon, and breast cancer patients’ survival
 
Findings reveal consistent racial disparities in ovarian, colon, and breast cancer patients’ survivalThree new articles present trends in survival for patients with ovarian, colon, and breast cancer in the United States by race and stage. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings reveal large, consistent, and persistent racial disparities in survival.